Published in
Elsevier, Lung Cancer, (147), p. 137-142, 2020
DOI: 10.1016/j.lungcan.2020.06.032
Links
Tools
Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: the phase II ATLANTIC study
Journal article published in 2020 by
Marina Chiara Garassino,
Byoung-Chul Cho 
,
Joo-Hang Kim,
Julien Mazières,
Johan Vansteenkiste,
Hervé Lena,
Jesus Corral Jaime,
Jhanelle E. Gray,
John Powderly,
Christos Chouaid,
Paolo Bidoli,
Paul Wheatley-Price,
Keunchil Park,
Ross A. Soo,
Lynne Poole
and other authors.
,
Joo-Hang Kim,
Julien Mazières,
Johan Vansteenkiste,
Hervé Lena,
Jesus Corral Jaime,
Jhanelle E. Gray,
John Powderly,
Christos Chouaid,
Paolo Bidoli,
Paul Wheatley-Price,
Keunchil Park,
Ross A. Soo,
Lynne Poole
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 